Figure 2

Overall improvements in the clinical activity indices (CAI) in two groups of patients with active UC receiving GMA or PSL. This figure shows average CAI values at baseline, at the time point when major UC symptoms were reduced and when patients achieved remission. No significant (ns) difference between the patients who received PSL and those who received the non-pharmacologic intervention, GMA was found.